Karboranyloporfiryny do stosowania w leczeniu raka

• 收藏
• 分享

专利权人:

MorEx Development Partners LLP

发明人:

BEATTIE CHRISTOPHER,WADSWORTH ANNE,RENNIE JAMES

申请号：

PL13737828

公开号：

PL2872176T3

申请日:

2013.07.11

申请国别(地区):

PL

年份:

2017

代理人:

摘要：

A porphyrin compound of Formula (1) is provided for use in cancer therapy that extends the period of time between the doses required while the patient is undergoing radiation therapy. The compound can be given not more often than once every 2 or more weeks, avoiding repeated administration, while radiation therapy can continue regularly.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/